Enlivex ENLV
NASDAQ ENLV
$0.47 -0.01 (-1.81%)
As of: Sep 30, 2026 · 10:24 AM EDT

Enlivex (ENLV) Cash from Restructuring (2015 - 2016)

Updated

Enlivex's Cash from Restructuring came in at -$70,000 for FY2016, compared with $70,000 in FY2015.

Analysis

Enlivex (ENLV) Cash from Restructuring (2015 - 2016) Analysis & Trends

  • Per Business Quant, earlier years put Cash from Restructuring at $70,000 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Enlivex 1.58 Mn -54.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 -125,000.00
Dec 31, 2015 19,000.00
Sep 30, 2015 19,000.00
Jun 30, 2015 19,000.00
API Access

Enlivex Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=ENLV&period=max&api_key=YOUR_API_KEY